Skip to main content

Table 1 Oligonucleotides used in this study

From: Development and validation of a FACS-based lipoprotein localization screen in the Lyme disease spirochete Borrelia burgdorferi

Numbera

Name

Target/Purpose

Sequence (5' to 3')b

1

Bsamut-fwd

Introduction of silent mutation in OspA L10 codon yielding Bsa I site

GGGAATAGGTCT C ATATTAGCCTTAATAGC

2

Bsamut-rev

Introduction of silent mutation in OspA L10 codon yielding Bsa I site

TGCTATTAAGGCTAATATG AGACC TATTCC

3

Bstmut-fwd

Introduction of silent mutation in mRFP1 V15R16 codons yielding Bst BI site

TGCGCTTCAAGGT T CG A A TGGAGGGCTCCG

4

Bstmut-rev

Introduction of silent mutation in mRFP1 V15R16 codons yielding Bst BI site

GGAGCCCTCCAT T CG A A CCTTGAAGCGCATGAAC

5

Rmut-oligo

Random mutagenesis oligo

TATTTATTGGGAATAGGTCTC ATATTAGCCTTAATAGCATGTAAGCAAAATGCCTCCTCCNNKNNK GTCATCAAGGAGTTCATGCGCTTCAAGGTTCGAA TGGAGGGCTCCGTG

6

Rmut-rev

Generation of double-stranded DNA from Rmut-oligo

CACGGAGCCCTCCATTCGAA CC

7

Mutscreen-fwd

Amplification of mutated ospA:mrfp1 region from PflaB

ATGCTATTGCTATTTGCGTTTC

8

Mutscreen-rev

Amplification of mutated ospA:mrfp1 region from ospA

ATGGTCTTCTTCTGCATTAC

9

Mutscreen-seq

Sequencing of amplified ospA:mrfp1 region from PflaB

AAAGGATTTGCCAAAGTCAG

  1. aNumbers correspond to primer numbers indicated in Figure 1.
  2. bIntroduced restriction sites are underlined; mutated nucleotides are in bold.